Cancer Research Cancer Epigenetics  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 1478, March 1, 2008. doi: 10.1158/0008-5472.CAN-07-6164
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sarkar, D.
Right arrow Articles by Fisher, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sarkar, D.
Right arrow Articles by Fisher, P. B.

Cell, Tumor, and Stem Cell Biology

Molecular Basis of Nuclear Factor-{kappa}B Activation by Astrocyte Elevated Gene-1

Devanand Sarkar1,2,4, Eun Sook Park1, Luni Emdad1,3,4, Seok-Geun Lee1,4, Zao-zhong Su1,4 and Paul B. Fisher1,2,3,4

Departments of 1 Urology, 2 Pathology, and 3 Neurosurgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York; and 4 Department of Human Genetics, Massey Cancer Center, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia

Requests for reprints: Devanand Sarkar, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0037. E-mail: dsarkar{at}vcu.edu and Paul B. Fisher, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0037. E-mail: pbfisher{at}vcu.edu.

Key Words: AEG-1, astrocyte elevated gene-1 • NF-{kappa}B, nuclear factor {kappa}B • PHFA, primary human fetal astrocytes • Invasion • Transcriptional regulation

Malignant glioma is a consistently fatal brain cancer. The tumor invades the surrounding tissue, limiting complete surgical removal and thereby initiating recurrence. Identifying molecules critical for glioma invasion is essential to develop targeted, effective therapies. The expression of astrocyte elevated gene-1 (AEG-1) increases in malignant glioma and AEG-1 regulates in vitro invasion and migration of malignant glioma cells by activating the nuclear factor-{kappa}B (NF-{kappa}B) signaling pathway. The present studies elucidate the domains of AEG-1 important for mediating its function. Serial NH2-terminal and COOH-terminal deletion mutants were constructed and functional analysis revealed that the NH2-terminal 71 amino acids were essential for invasion, migration, and NF-{kappa}B–activating properties of AEG-1. The p65-interaction domain was identified between amino acids 101 to 205, indicating that p65 interaction alone is not sufficient to mediate AEG-1 function. Coimmunoprecipitation assays revealed that AEG-1 interacts with cyclic AMP-responsive element binding protein–binding protein (CBP), indicating that it might act as a bridging factor between NF-{kappa}B, CBP, and the basal transcription machinery. Chromatin immunoprecipitation assays showed that AEG-1 is associated with the NF-{kappa}B binding element in the interleukin-8 promoter. Thus, AEG-1 might function as a coactivator for NF-{kappa}B, consequently augmenting expression of genes necessary for invasion of glioma cells. In these contexts, AEG-1 represents a viable potential target for the therapy of malignant glioma. [Cancer Res 2008;68(5):1478–84]




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Sarkar, L. Emdad, S.-G. Lee, B. K. Yoo, Z.-z. Su, and P. B. Fisher
Astrocyte Elevated Gene-1: Far More Than Just a Gene Regulated in Astrocytes
Cancer Res., November 15, 2009; 69(22): 8529 - 8535.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Hu, Y. Wei, and Y. Kang
The Multifaceted Role of MTDH/AEG-1 in Cancer Progression
Clin. Cancer Res., September 15, 2009; 15(18): 5615 - 5620.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. K. Yoo, R. Gredler, N. Vozhilla, Z.-z. Su, D. Chen, T. Forcier, K. Shah, U. Saxena, U. Hansen, P. B. Fisher, et al.
Identification of genes conferring resistance to 5-fluorouracil
PNAS, August 4, 2009; 106(31): 12938 - 12943.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Yu, K. Chen, H. Zheng, X. Guo, W. Jia, M. Li, M. Zeng, J. Li, and L. Song
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis
Carcinogenesis, May 1, 2009; 30(5): 894 - 901.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z.-z. Su, S.-G. Lee, L. Emdad, I. V. Lebdeva, P. Gupta, K. Valerie, D. Sarkar, and P. B. Fisher
Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN)
PNAS, December 30, 2008; 105(52): 20906 - 20911.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. de la Iglesia, G. Konopka, K.-L. Lim, C. L. Nutt, J. F. Bromberg, D. A. Frank, P. S. Mischel, D. N. Louis, and A. Bonni
Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness
J. Neurosci., June 4, 2008; 28(23): 5870 - 5878.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.